Substance use during pregnancy is more common than most people realize, and it rarely looks the way people expect. Research from SAMHSA indicates that millions of pregnant women in the United States report using alcohol, tobacco, or illicit substances each year, with many going undetected until delivery. Recognizing the signs of drug addiction during pregnancy early can meaningfully change outcomes for both mother and child. When identified and addressed in a timely way, addiction during pregnancy can be treated safely and effectively, giving the pregnancy a more stable foundation.
The physical and behavioral changes that accompany substance use during pregnancy often overlap with typical pregnancy symptoms, which is part of why they go unnoticed for so long. Fatigue, nausea, mood shifts, and weight changes can all be attributed to the pregnancy itself rather than an underlying substance use disorder. Understanding what distinguishes normal pregnancy discomfort from signs of active substance use can help partners, family members, and healthcare providers intervene without judgment. Early, compassionate intervention gives pregnant women the best chance at accessing care that supports both their health and their baby’s development. Resources exist specifically for pregnant women, including treatment programs that coordinate prenatal care alongside addiction treatment, so no one has to choose between getting help and protecting their pregnancy.
Table of Contents
Physical and Behavioral Signs of Substance Use During Pregnancy
Certain physical changes during pregnancy become concerning when they fall outside the expected range. Sudden or significant weight loss, poor hygiene that represents a shift from the person’s baseline, track marks or skin lesions, and extreme fluctuations in energy levels all warrant a closer, non-judgmental look. A pregnant woman using opioids may appear sedated, nod off mid-conversation, or have constricted pupils. Someone using stimulants like methamphetamine or cocaine may show rapid weight loss, insomnia, agitation, or dental deterioration that worsens quickly.
Behavioral indicators are often just as telling as physical ones. Missed prenatal appointments, erratic or secretive behavior, sudden financial problems, and withdrawal from relationships that were previously stable can all point to an active substance use disorder. A review of how someone is showing signs of acute intoxication can also help distinguish substance use from other medical or mental health concerns. Behavioral changes alone are rarely diagnostic, but they provide important context when combined with physical observations.
Healthcare providers use clinical tools including urine toxicology screening, meconium testing, and umbilical cord tissue analysis to detect prenatal substance exposure. The Finnegan Neonatal Abstinence Scoring Tool is used after birth to assess the severity of withdrawal in newborns. These screening methods exist because visible signs alone are insufficient for accurate identification. Screening is most effective when combined with open, shame-free conversations between providers and patients during prenatal care visits.
Why Pregnant Women Often Hide Substance Use
Fear drives concealment more than dishonesty does. Pregnant women with substance use disorders frequently withhold information from doctors, partners, and family members because they fear losing custody, facing criminal charges, or being judged as unfit mothers. This fear is not unfounded. In many states, substance use during pregnancy carries legal consequences, which creates a powerful disincentive to seek help. That barrier directly delays treatment and increases risk for both the mother and the developing baby.
Shame compounds the fear. Addiction is still misunderstood by many people as a moral failing rather than a chronic medical condition with neurological roots. A pregnant woman carrying that shame may isolate herself, avoid prenatal care, or minimize her use when asked directly by a provider. Research consistently shows that non-judgmental, trauma-informed screening approaches significantly increase honest disclosure. When a provider creates psychological safety, patients are more likely to tell the truth and accept a referral to treatment. For those exploring what drug addiction treatment looks like in practice, understanding this dynamic is a critical first step.
Many pregnant women with substance use disorders also lack accurate information about their options. They may not know that medication-assisted treatment with buprenorphine or methadone is considered the standard of care during pregnancy for opioid use disorder. They may not know that specialized programs exist to treat addiction without separating them from their children or their prenatal care team. Closing those information gaps is one of the most direct ways to increase treatment engagement among this population.
The Risks of Untreated Addiction to Mother and Baby
Untreated substance use during pregnancy carries documented, serious risks that affect every stage of development. According to the CDC and ACOG, prenatal opioid exposure is linked to Neonatal Abstinence Syndrome (NAS), a cluster of withdrawal symptoms in newborns that includes high-pitched crying, tremors, poor feeding, and seizures in severe cases. Cocaine and methamphetamine use during pregnancy are associated with placental abruption, preterm labor, and intrauterine growth restriction. Alcohol exposure at any stage of fetal development can result in Fetal Alcohol Spectrum Disorders (FASDs), which have no cure and carry lifelong consequences.
The maternal risks are equally serious. Pregnant women with untreated substance use disorders face elevated rates of preeclampsia, infection, anemia, and overdose. A sudden relapse during pregnancy, particularly with opioids, carries a higher overdose risk because tolerance decreases quickly. Beyond physical health, untreated addiction during pregnancy is one of the strongest predictors of postpartum mental health crises, including postpartum depression and anxiety. These risks do not exist in isolation from each other; they interact and compound over the course of the pregnancy.
Long-term outcomes for children born to mothers with untreated substance use disorders extend well beyond the newborn period. Studies show elevated rates of developmental delays, attention difficulties, learning disabilities, and behavioral challenges in children with significant prenatal substance exposure. These outcomes are not inevitable, particularly when stable, nurturing caregiving environments and early intervention services are in place. Treatment during pregnancy is not just about protecting the baby at birth; it shapes years of developmental potential. Connecting with medically supervised detox and stabilization early in pregnancy significantly reduces many of these downstream risks.
How to Get Confidential Help During Pregnancy
Pregnant women have the legal right to seek addiction treatment confidentially in most circumstances, and federal law protects the privacy of substance use disorder treatment records under 42 CFR Part 2. Knowing that confidentiality is protected removes one of the most common barriers to seeking help. Providers who specialize in treating pregnant women are trained to coordinate care between obstetrics, addiction medicine, and mental health services simultaneously. That coordination matters because addressing only one dimension of the problem consistently produces worse outcomes.
The most effective approach to addiction treatment during pregnancy combines medication-assisted treatment when clinically indicated with behavioral therapy, prenatal care, and trauma-informed counseling. Partial Hospitalization Programs (PHP) and Intensive Outpatient Programs (IOP) are structured options that allow a woman to engage in high-intensity treatment while maintaining more flexibility than residential care. Peer support specialists with lived experience in pregnancy and recovery can also play a meaningful role in building trust and engagement. The goal is stability, not perfection, and treatment that acknowledges the full complexity of a person’s life tends to produce more durable results.
Several concrete steps can help a pregnant woman or a concerned loved one begin accessing care. Reaching out directly to an addiction treatment program that specializes in pregnant or parenting women is the most direct path. The following steps outline where to begin:
- Contact a treatment program that coordinates with OB providers
- Ask specifically about confidentiality protections before disclosing
- Request a medication-assisted treatment evaluation from a licensed provider
- Inquire about PHP or IOP levels of care that fit the pregnancy timeline
- Seek programs with trauma-informed, gender-responsive clinical staff
Taking the first step toward treatment is often the hardest, but it is also the one with the most immediate impact on both the pregnancy and the recovery process.
Frequently Asked Questions About Drug Use and Addiction During Pregnancy
These are some of the questions people most often ask when trying to understand substance use during pregnancy and what can be done about it:
What are the most common physical signs that a pregnant woman may be using substances?
Sudden weight loss, unexplained skin lesions, constricted or dilated pupils, extreme fatigue, and poor hygiene that represents a clear change from baseline are among the most observable physical indicators. These signs are most meaningful when combined with behavioral shifts such as missed prenatal appointments or increased secrecy.
Which substances cause the most serious complications during pregnancy?
Opioids, alcohol, methamphetamine, and cocaine carry the highest documented risk for fetal harm and maternal complications. Opioids in particular are linked to Neonatal Abstinence Syndrome, while alcohol is the leading preventable cause of developmental disability in children through Fetal Alcohol Spectrum Disorders.
How do doctors detect prenatal drug exposure in a newborn?
Clinical teams use a combination of newborn withdrawal scoring tools, urine toxicology, meconium testing, and umbilical cord tissue screening to identify prenatal substance exposure at birth. The Finnegan Neonatal Abstinence Scoring System is widely used to assess the severity of withdrawal symptoms in the newborn period.
What are the long-term developmental effects on children born with prenatal substance exposure?
Children with significant prenatal substance exposure are at elevated risk for attention difficulties, learning disabilities, speech and language delays, and behavioral regulation challenges that persist into school age and beyond. Stable, nurturing caregiving environments and access to early intervention services can meaningfully reduce the severity of these outcomes.
Is medication-assisted treatment safe to use during pregnancy?
Buprenorphine and methadone are both considered the standard of care for opioid use disorder during pregnancy by ACOG and other leading medical organizations. These medications stabilize the pregnancy, reduce overdose risk, and allow the mother to engage more fully in prenatal care and behavioral treatment.
What is Neonatal Abstinence Syndrome and how is it treated?
Neonatal Abstinence Syndrome, or NAS, refers to the constellation of withdrawal symptoms a newborn experiences when prenatal substance exposure ends at birth. Treatment typically involves non-pharmacological comfort measures, close monitoring, and in more severe cases, carefully dosed medications to manage symptoms safely in a neonatal care setting.
Key Takeaways on Signs of Drug Addiction During Pregnancy
- Physical signs of drug addiction during pregnancy include weight loss, track marks, pupil changes, and erratic energy levels
- Fear of legal consequences and stigma are the primary reasons pregnant women delay disclosing substance use
- Untreated addiction during pregnancy raises the risk of NAS, preterm birth, placental abruption, and long-term developmental challenges
- Medication-assisted treatment with buprenorphine or methadone is clinically recommended for opioid use disorder during pregnancy
- Confidential, trauma-informed treatment programs that integrate prenatal care produce better outcomes for mothers and newborns
Substance use during pregnancy is a medical issue, not a measure of character. Treatment is available at every trimester, and accessing it earlier consistently leads to better outcomes for both mother and child.
If you or someone you care about is pregnant and struggling with substance use, Grace Point Treatment Center in Fort Lauderdale offers compassionate, individualized care for pregnant women navigating addiction and recovery. The clinical team provides trauma-informed treatment that coordinates with prenatal care providers to support the full picture of health. Reach out confidentially at 754-666-8104 to speak with someone who understands the complexity of this moment and can help you take the next step.
